Fourth, the close relationship of copeptin release with the body’s stress responses and the potential increase of plasma copeptin levels in the setting of medical comorbidity may interfere with the prognostic utility of copeptin among hospitalized stroke patients. This evidence concerns the gene AVP and stroke disorder.